Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Compass Therapeutics Inc (NASDAQ: CMPX) closed the day trading at $2.16 down -8.65% from the previous closing price of $2.37. In other words, the price has decreased by -$8.65 from its previous closing price. On the day, 0.9 million shares were traded. CMPX stock price reached its highest trading level at $2.4 during the session, while it also had its lowest trading level at $2.13.
Ratios:
For a better understanding of CMPX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.96 and its Current Ratio is at 14.96. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on February 24, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On February 19, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $12.
On December 23, 2024, D. Boral Capital started tracking the stock assigning a Buy rating and target price of $32.D. Boral Capital initiated its Buy rating on December 23, 2024, with a $32 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 299380512 and an Enterprise Value of 179293616. For the stock, the TTM Price-to-Sale (P/S) ratio is 352.21 while its Price-to-Book (P/B) ratio in mrq is 2.38. Its current Enterprise Value per Revenue stands at 210.934 whereas that against EBITDA is -3.2.
Stock Price History:
The Beta on a monthly basis for CMPX is 1.06, which has changed by 0.056097507 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, CMPX has reached a high of $4.08, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is -23.72%, while the 200-Day Moving Average is calculated to be 21.63%.
Shares Statistics:
Over the past 3-months, CMPX traded about 1.54M shares per day on average, while over the past 10 days, CMPX traded about 917530 shares per day. A total of 137.82M shares are outstanding, with a floating share count of 80.70M. Insiders hold about 41.64% of the company’s shares, while institutions hold 38.87% stake in the company. Shares short for CMPX as of 1741910400 were 4607296 with a Short Ratio of 2.41, compared to 1739491200 on 3534626. Therefore, it implies a Short% of Shares Outstanding of 4607296 and a Short% of Float of 4.7.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current rating of Compass Therapeutics Inc (CMPX) reflects the combined expertise of 9.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.05 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.19 and -$0.6 for the fiscal current year, implying an average EPS of -$0.44. EPS for the following year is -$0.42, with 9.0 analysts recommending between $0.19 and -$0.75.
Revenue Estimates
Based on 10 analysts’ estimates, the company’s revenue will be $46.06M in the next fiscal year. The high estimate is $126.33M and the low estimate is $13.75M.
